Lung Cancer Screening Programs Hit the Mark on Eligibility Criteria However, adherence to follow-up screening is "suboptimal" Oct 10, 2022
Former Smokers See Even Better Outcomes With Healthier Lifestyles Managing body weight, diet, and more seemed to lower premature death risk Sep 26, 2022
FDA Grants First Tumor-Agnostic Approval for RET Fusion-Positive Cancers Selpercatinib approved for advanced or metastatic solid tumors that progress on systemic therapy Sep 22, 2022
Sleep Experts Issue Advisory on Melatonin in Children Recommendations come as reported pediatric poisonings surged Sep 22, 2022
Does Poor Air Quality Send More Kids With Autism to the Hospital? South Korean study looked at effects of short-term exposure on ASD-related outcomes Sep 21, 2022
Not Just Recalls: Philips Tangles With Law Enforcement Company agreed to pay $24 million to settle whistleblower lawsuit Sep 21, 2022
In Wake of Philips Recall, Patients Still Waiting for Sleep Apnea Devices Effects of recall reverberate through sleep medicine community Sep 21, 2022
No Weird Dreams for Insomnia Patients Taking Lemborexant Even at 10 mg, the sleep aid resulted in few abnormal dreams or nightmares Sep 20, 2022
Trazodone Commonly Used Off-Label for Insomnia Not much data to support efficacy or safety "as a surrogate hypnotic medication," researcher says Sep 20, 2022
Early Tamiflu Linked to Better Outcomes for Kids Hospitalized for the Flu Early use of antiviral associated with shorter length of stay, lower odds of 7-day readmission Sep 19, 2022
KRAS Inhibitor Tops Docetaxel for Previously Treated NSCLC "New second-line standard" in KRAS G12C-mutant disease, says study investigator Sep 13, 2022
Survival Bump in Unfit NSCLC With First-Line Immunotherapy Atezolizumab doubles OS at 2 years versus chemotherapy in those ineligible for platinum doublets Sep 12, 2022
Combination Therapy Shows Promise for NSCLC That Progresses on Osimertinib About half of patients responded to tepotinib plus osimertinib, but efficacy ceiling persists Sep 12, 2022
Locking Down a Link Between Pollution and EGFR-Mutated Lung NSCLC Study also shed lights on what may lead to lung cancer in never smokers Sep 11, 2022
Taking Two Common Supplements in Pregnancy Reduced Risk of Croup in Kids Fish oil and high-dose vitamin D led to 38% and 40% reduced risks of croup in kids under age 3 Sep 09, 2022
DPP-1 Blocker a Bust in Severe COVID Deaths in hospitalized patients significantly higher with oral brensocatib, trial finds Sep 08, 2022
Study: Microwave Ablation for Lung Nodules Effective as Last Resort Good option for patients who can't have surgery or radiotherapy, surgeon says Sep 08, 2022
Less Invasive Emphysema Treatment Matches Lung Volume Reduction Surgery Bronchoscopic lung volume reduction with valve placement gets a boost from CELEB trial Sep 08, 2022
Are Antibiotics Needed for Moderate Acute Exacerbations of COPD? Maybe not for one subgroup of patients, says study from Germany Sep 06, 2022
Nalbuphine Shows 'Clear Benefit' for IPF Chronic Cough in Early Trial Proof-of-concept study with opioid agonist/antagonist showed 77% reduction in cough frequency Sep 06, 2022
Pirfenidone Shows Hints of Benefit for RA-Related Lung Disease But early halt to recruitment, forced by pandemic, left trial underpowered Sep 06, 2022
How to Save 5 Minutes in Evaluating Patients Post-COVID Some "simple" tests are simpler than others Sep 06, 2022
Mucus Too Sticky? NAC Injections May Help Trial shows benefit with IV N-acetylcysteine in hospital setting Sep 05, 2022
Dual Bronchodilators No Help for Symptomatic Smokers With Preserved Lung Function RETHINC highlights why clinicians cannot keep giving these patients COPD meds, researcher says Sep 04, 2022
Radiofrequency Tx Proves on the Nose for Collapsed Nasal Valves Improvements with temperature-controlled radiofrequency therapy maintained through 1 year Sep 01, 2022
High-Dose Flu Vaccine Promising for Mortality Benefits in Older Adults Danish pilot study lays groundwork for larger trial looking for better CV outcomes Aug 28, 2022
After Cardiac Arrest, No 'Best' Blood Pressure, Oxygen Target BOX trial finds targets aiming to boost perfusion held no advantage Aug 27, 2022
Lowering Antenatal Betamethasone Dose Misses in Randomized Trial In BETADOSE study, half-dose regimen fails to meet noninferiority criteria Aug 22, 2022
A Legacy of the Deepwater Horizon Spill: Asthma in Cleanup Workers Risk related to airborne chemicals from burning oil, natural gas Aug 19, 2022
Nothing Lasts Forever, Including Infant BCG Vaccine Protection Most efficacy lost by age 5 Aug 11, 2022
'Clinically Meaningful' Improvement in SCLC Patients With Pembrolizumab/Chemo Combo Long-term follow-up shows continued survival benefit as first-line treatment Aug 11, 2022
Brain Structure, Cognitive Performance Linked With Tobacco Use in Kids Impairments seen through 2 years of follow-up Aug 10, 2022
Triple Therapy Continues to Impress in Metastatic NSCLC With High-Risk Mutations Meaningful survival boosts in POSEIDON trial of front-line durvalumab, tremelimumab, and chemo Aug 10, 2022
Survey: 77% of Women With Lung Cancer Report Sexual Dysfunction Results show need to integrate sexual health into care, researcher says Aug 09, 2022
Neodjuvant Chemoimmunotherapy Takes Another Step Forward in Stage IIIA-B NSCLC Phase II trial supports neoadjuvant nivolumab plus chemotherapy Aug 09, 2022
New Data Bolster Atezolizumab as Adjuvant Tx in NSCLC Overall survival benefit now demonstrated Aug 09, 2022
Low-Dose Sotorasib 'Lead-in' Strategy Promising in NSCLC Subset Early phase results set the stage for KRAS/immune-targeted combo as potential first-line option Aug 08, 2022
Sublobar Resection the 'New Standard of Care' in Small-Sized NSCLC? Large randomized study shows non-inferiority to lobectomy Aug 08, 2022
Global COPD Burden; Driving Restrictions After Fainting? Also in TTHealthWatch: best meds for insomnia and the effect of calorie labels in supermarkets Aug 06, 2022 podcast
Pneumococcal Vax Slashed Deadly Sickle-Cell Complication in Kids Cumulative ACS reduction of 41% since implementation of 13-valent vaccine, French study finds Aug 02, 2022
